BIOMARKER:

MAP2K1 P124S

Entrez ID:

Related biomarkers:

‹

›

MAP2K1 P124S MAP2K1 P124S	Melanoma Melanoma	trametinib Sensitive: C3 – Early Trials
MAP2K1 P124S MAP2K1 P124S	Melanoma Melanoma	dabrafenib Resistant: C3 – Early Trials
MAP2K1 P124S MAP2K1 P124S	Melanoma Melanoma	vemurafenib Resistant: C3 – Early Trials
MAP2K1 P124S MAP2K1 P124S	Melanoma Melanoma	selumetinib Sensitive: C4 – Case Studies
MAP2K1 P124S MAP2K1 P124S	Melanoma Melanoma	PLX4720 Resistant: D – Preclinical

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

Associations